Additionally, high SLC7A11 expression has been shown to promote the accumulation of immunosuppressive cells, such as myeloid-derived suppressor cells (MDSCs), within the TME, further inhibiting effector T cell activity and diminishing the efficacy of anti-tumor immune responses [26, 27]. This evidence concerns the gene SLC7A11 and neoplasm.